Pharmaceutical Executive
June 08, 2017
Features
37
5
In its 11th annual feature, Pharm Exec breaks a bit from the norm, to instead profile five products that are shining the spotlight on five critical and highly debated aspects of healthcare and R&D at the moment.
May 17, 2017
Features
37
5
With this year marking our 11th installment, we look back on Pharm Exec's first 10 Brands of the Year-why they were chosen and the challenges, changes, and successes since.
May 12, 2017
Features
37
5
For pharma, diagnosing what ails or strengthens performance in this critical corporate discipline may help reshape business prognosis.
May 09, 2017
Features
37
5
Study examines why a pharma brand’s early sales are not a trusted predictor for total lifetime value-it’s about driving waves of growth.
May 08, 2017
Columns
37
5
New DTC campaign for its vaccine Zostavax uses a more serious, personal messaging approach-as pharmas look to close the conversation gaps between patients and healthcare providers.
May 04, 2017
Columns
37
5
Payers and pharma companies seek outcomes data for evidence-based reimbursement deals.
May 04, 2017
From the Editor
37
5
Recent PR disasters in other industries raise an important reputational question that can apply to pharma as well: do you want to be someone that works the system or improves the system?
May 01, 2017
Columns
37
5
If pharma companies want to hold their own in the current climate, they must embrace rather than resist market change.
May 01, 2017
Columns
37
5
Grant-boosted Euripid pushes revitalized defense of external reference pricing system.
May 01, 2017
Special Sponsored Section
37
5
Home to some of the world’s most important international health institutions and some big pharma players as well, Switzerland lays claim as a healthcare and life sciences powerhouse. Navigating its pharmaceutical market terrain, however, does not come without its challenges.
May 01, 2017
Issue PDF
37
5
Click the title above to open the Pharmaceutical Executive May 2017 issue in an interactive PDF format.